Forte Biosciences

What experts have said about Forte Biosciences

3 statements · 3 positive

1. Carol MassarPositiveJul 27, 2026· Stock Movers

   Organics agreed to acquire Forte Biosciences for $77 per share, valuing equity at about $2.2 billion.

   “this one also some outperformance jumping about 40% after Organics agreed to acquire the biotech at $77 a share in cash representing a total equity value of about 2.2 billion.”

   Listen at 2:36

   Open the episode · Closing Bell: Meatpackers Gain, Nvidia Drops, Fertilizer Names Fall
2. Avalon PurnellPositiveJul 10, 2026· Stock Movers

   Forte Biosciences reported positive early-stage clinical data for its vitiligo drug.

   “reporting some pretty positive early stage clinical data for its Vitiligo drug”

   Listen at 2:42

   Open the episode · Weekly Roundup: Meta's Big Week, Paramount Skydance Mixed, Forte Biosciences Soars
3. Avalon PurnellPositiveJul 10, 2026· Stock Movers

   Forte Biosciences’ clinical data lifted peers including First Tracks Biotherapeutics.

   “it also pushed up some of its peers as well, like First Tracks Biotherapeutics, which is pursuing a similar molecule for a different therapy area”

   Listen at 2:46

   Open the episode · Weekly Roundup: Meta's Big Week, Paramount Skydance Mixed, Forte Biosciences Soars

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

• Jul 27, 2026Argenx buys Forte Biosciences for billions as media merger talks stallStock MoversJul 27, 2026
• Jul 27, 2026Nvidia considers massive OpenAI backstop while biotech and telecom sectors surgeStock MoversJul 27, 2026
• Jul 10, 2026Meta jumps and Forte Biosciences surges while Paramount Skydance slides on debtStock MoversJul 10, 2026